Cibc World Market Inc. Takes Position in DENTSPLY SIRONA Inc. $XRAY

Cibc World Market Inc. acquired a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 1,351,619 shares of the medical instruments supplier’s stock, valued at approximately $14,341,000. Cibc World Market Inc. owned about 0.68% of DENTSPLY SIRONA as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Eurizon Capital SGR S.p.A. acquired a new position in DENTSPLY SIRONA in the 4th quarter worth approximately $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in DENTSPLY SIRONA during the 1st quarter valued at approximately $26,000. Caitong International Asset Management Co. Ltd lifted its stake in DENTSPLY SIRONA by 337.9% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 2,750 shares of the medical instruments supplier’s stock valued at $35,000 after acquiring an additional 2,122 shares during the period. Farther Finance Advisors LLC boosted its holdings in shares of DENTSPLY SIRONA by 119.1% in the 4th quarter. Farther Finance Advisors LLC now owns 3,773 shares of the medical instruments supplier’s stock valued at $43,000 after acquiring an additional 2,051 shares during the last quarter. Finally, Performa Ltd US LLC boosted its holdings in shares of DENTSPLY SIRONA by 116.1% in the 4th quarter. Performa Ltd US LLC now owns 4,250 shares of the medical instruments supplier’s stock valued at $49,000 after acquiring an additional 2,283 shares during the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

Insider Activity

In other DENTSPLY SIRONA news, Director Brian T. Gladden bought 9,985 shares of DENTSPLY SIRONA stock in a transaction dated Monday, June 15th. The stock was acquired at an average cost of $10.02 per share, with a total value of $100,049.70. Following the purchase, the director directly owned 61,849 shares in the company, valued at $619,726.98. This represents a 19.25% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Michael J. Barber bought 15,175 shares of the firm’s stock in a transaction dated Thursday, June 11th. The shares were acquired at an average price of $9.88 per share, for a total transaction of $149,929.00. Following the transaction, the director directly owned 55,943 shares in the company, valued at approximately $552,716.84. This represents a 37.22% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired 35,160 shares of company stock worth $351,179 over the last three months. 0.46% of the stock is currently owned by corporate insiders.

DENTSPLY SIRONA Trading Down 0.3%

Shares of DENTSPLY SIRONA stock opened at $10.89 on Tuesday. The firm has a 50-day simple moving average of $12.04 and a two-hundred day simple moving average of $11.79. The company has a debt-to-equity ratio of 1.48, a quick ratio of 1.07 and a current ratio of 1.63. DENTSPLY SIRONA Inc. has a fifty-two week low of $9.40 and a fifty-two week high of $14.86. The company has a market cap of $2.17 billion, a P/E ratio of -3.96, a price-to-earnings-growth ratio of 1.38 and a beta of 0.85.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 EPS for the quarter, beating analysts’ consensus estimates of $0.35 by $0.17. The firm had revenue of $898.00 million for the quarter, compared to analysts’ expectations of $889.93 million. DENTSPLY SIRONA had a positive return on equity of 20.84% and a negative net margin of 14.99%.The company’s quarterly revenue was down 4.1% on a year-over-year basis. During the same period last year, the firm earned $0.52 EPS. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. As a group, equities analysts predict that DENTSPLY SIRONA Inc. will post 1.41 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research analysts recently issued reports on XRAY shares. Piper Sandler raised their target price on shares of DENTSPLY SIRONA from $13.00 to $14.00 and gave the stock a “neutral” rating in a report on Wednesday, July 29th. UBS Group lowered their price target on shares of DENTSPLY SIRONA from $18.00 to $17.00 and set a “buy” rating on the stock in a report on Thursday, May 7th. BMO Capital Markets reiterated a “market perform” rating and set a $13.00 price objective on shares of DENTSPLY SIRONA in a research note on Friday, August 7th. Weiss Ratings reiterated a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research note on Monday, August 3rd. Finally, Mizuho decreased their price objective on DENTSPLY SIRONA from $16.00 to $14.00 and set a “neutral” rating for the company in a report on Wednesday, May 6th. Three research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $13.54.

About DENTSPLY SIRONA

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.